【结 构 式】 |
【分子编号】33756 【品名】butyl 2-[(5R)-3-(4-cyanophenyl)-4,5-dihydro-5-isoxazolyl]acetate 【CA登记号】 |
【 分 子 式 】C16H18N2O3 【 分 子 量 】286.3306 【元素组成】C 67.12% H 6.34% N 9.78% O 16.76% |
与该中间体有关的原料药合成路线共 1 条
合成路线1
该中间体在本合成路线中的序号:(XIIb),(XIII)In a further procedure, lipase-mediated hydrolysis of the racemic n-butyl ester (XII) provided the required (R)-acid (XI) along with unreacted (S)-ester (XIII), which was recycled through racemization using potassium tert-butoxide.
【1】 Wityak, J.; Sielecki, T.M.; Xue, C.-B.; et al.; Discovery of an orally active series of isoxazoline glycoprotein IIb/IIIa antagonists. J Med Chem 1997, 40, 13, 2064-84. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(XIIa) | 33755 | butyl 2-[(5S)-3-(4-cyanophenyl)-4,5-dihydro-5-isoxazolyl]acetate | C16H18N2O3 | 详情 | 详情 | |
(XIIb),(XIII) | 33756 | butyl 2-[(5R)-3-(4-cyanophenyl)-4,5-dihydro-5-isoxazolyl]acetate | C16H18N2O3 | 详情 | 详情 | |
(XI) | 33754 | 2-[(5S)-3-(4-cyanophenyl)-4,5-dihydro-5-isoxazolyl]acetic acid | C12H10N2O3 | 详情 | 详情 |
Extended Information